Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors
2 other identifiers
interventional
120
1 country
1
Brief Summary
Digital mental and behavioral health interventions have potential to significantly improve accessibility for the large number of breast cancer survivors who need treatments. However, the landscape of digital interventions tested in this population remains limited, with the few that have been tested primarily focused on reducing symptoms of mental disorders. This is problematic given the range of psychosocial needs among breast cancer survivors, including those who may not have active mental health symptoms, yet could benefit from learning effective coping skills. Moreover, all of these interventions follow a "one size fits all" approach, lacking precision in terms of when, where, and to whom they should be given. The overarching goals of this project are to develop and pilot a variety of digital micro-interventions (DMIs) for breast cancer survivors - highly focused, technology-enabled interventions that can be delivered in the context of a person's daily life with little burden on the individual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 12, 2025
CompletedFirst Submitted
Initial submission to the registry
August 29, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedMay 4, 2026
April 1, 2026
8 months
August 29, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of Digital Micro-Intervention
12 item scale measuring satisfaction and acceptability. Each question is scored on a 0-4 scale with a total raw summed score range of 0-48. Higher scores indicate greater satisfaction and acceptability.
Post 1 week
Secondary Outcomes (12)
PROMIS-29 Profile
Baseline
PROMIS-29 Profile
Post 1 week
Pain, Enjoyment of Life and General Activity (PEG) Scale
Baseline
Pain, Enjoyment of Life and General Activity (PEG) Scale
Post 1 week
Emotion Regulation Questionnaire
Baseline
- +7 more secondary outcomes
Other Outcomes (1)
Qualitative Interview
Post 1 week
Study Arms (6)
Savoring
EXPERIMENTALParticipants are asked to think of a positive and personally meaningful memory to meditate on. They are led through steps to enter their memory, which is then summarized and turned into a meditation practice.
Gratitude
EXPERIMENTALParticipants are asked to generate a list of things they are grateful for. They are led through an automated process of selecting a source of gratitude and reflecting on it.
Challenging UnhelpfulThoughts
EXPERIMENTALParticipants are taught how to identify unhelpful thoughts, challenge them, and generate more balanced, helpful thoughts through an automated process that leads them step-by-step.
Psychoeducation
EXPERIMENTALParticipants receive access to psychoeducation content on mental health, distress, and well-being. They are provided tidbits of information every day to learn from.
Behavioral Activation
EXPERIMENTALParticipants are led through an automated process of identifying tasks they can accomplish in their daily lives.
Acceptance
EXPERIMENTALParticipants are led through an automated process of accepting, rather than actively trying to push away, their distressing emotions or thoughts.
Interventions
Digital Micro-Interventions are brief interventions that target specific behavioral and cognitive mechanisms of mental health, designed for brief periods of engagement.
Eligibility Criteria
You may qualify if:
- Age = 18 years.
- years post-diagnosis of Stage I, II, or III female breast cancer.
- Elevated symptoms of depression and/or anxiety as measured by the PHQ-8 (score \> 9) or GAD-7 (score \> 7).
You may not qualify if:
- Receiving individual (1 on 1) treatment for depression and/or anxiety to avoid treatment interference (note, individuals will be permitted to enroll if they are taking antidepressant medication and have not had an appointment to adjust the dosage over the past 2 weeks)
- Active suicidal ideation during the enrollment/screening call based on a trained staff member orally administering the suicidality item from the PHQ-9 to individuals on the phone ("In the last 2 weeks, have you had thoughts that you would be better off dead, or thoughts of hurting yourself in some way?"). If an individual responds in any way other than "not at all" based on the available response options (i.e., either "several days", "more than half the days", or "nearly every day"), or if they mention having suicidal ideation or thoughts of death during the enrollment/screening call, the Pitt-Optimum risk assessment tool will be administered. Only participants deemed low risk may proceed in enrollment; all will be given additional resources.
- Do not have an app-compatible phone (i.e., iOS 10.3 or later or Android 4.0.3 or later).
- Cannot read and speak English (interventions only available in English).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Virginialead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22904, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 29, 2025
First Posted
September 8, 2025
Study Start
August 12, 2025
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share